Unheard of to have a trial with 19 participants show statistical signifigance easily beating .05 standard.....
Big pharma runs trials with 5000 patients to show an overall benefit of life extension for a month that has huge side effects. And they call that a great new drug...Pfff to the drugs that dont cure,have horendous side effects and effectivness decreases quickly.
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Grants Orphan Drug Designation for Revascor
Ann: FDA Grants Orphan Drug Designation for Revascor, page-273
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.03 |
Change
0.080(8.42%) |
Mkt cap ! $1.084B |
Open | High | Low | Value | Volume |
95.5¢ | $1.03 | 95.0¢ | $1.549M | 1.570M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 7645 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 70330 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 46983 | 0.960 |
10 | 38484 | 0.955 |
7 | 45929 | 0.950 |
2 | 14875 | 0.945 |
4 | 38066 | 0.940 |
Price($) | Vol. | No. |
---|---|---|
0.965 | 30252 | 5 |
0.970 | 39309 | 7 |
0.975 | 90946 | 8 |
0.980 | 120173 | 10 |
0.985 | 132450 | 7 |
Last trade - 10.26am 30/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |